[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]

Schweiz Med Wochenschr. 1996 Oct 26;126(43):1845-8.
[Article in French]

Abstract

Zidovudine (ZDV) was the most widely used anti-HIV drug between 1987 and 1995, and, as already reported, transmission of ZDV-resistant viruses occurs. Several mutations of the reverse transcriptase gene have been identified; one of them affects the 215 codon and is associated with a high degree of resistance. We have determined, using selective PCR, the prevalence of transmission of 215 mutant isolates in 134 patients with primary HIV infection (PHI) and have identified 8 patients with 215 mutant virus between 1989 and 1995 in Switzerland. Mutant resistant viruses have been isolated from patients treated with most antiviral drugs. A systematic search for mutant viruses may provide useful information for the adaptation of treatment strategies.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antiviral Agents / pharmacology*
  • Base Sequence
  • DNA, Viral / genetics
  • Drug Resistance / genetics
  • Female
  • HIV / drug effects*
  • HIV / genetics
  • HIV Infections / transmission*
  • HIV Reverse Transcriptase / genetics
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Zidovudine / pharmacology*

Substances

  • Antiviral Agents
  • DNA, Viral
  • Zidovudine
  • HIV Reverse Transcriptase